Clinical Trials in Nancy, Meurthe-et-Moselle
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC614 enrolled218 locationsNCT06170788
Recruiting
Phase 2Phase 3
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Focal Epilepsy
Biohaven Therapeutics Ltd.390 enrolled124 locationsNCT06132893
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Alzheimer s Disease
Bristol-Myers Squibb586 enrolled123 locationsNCT06976203
Recruiting
Unruptured Cerebral Aneurysm: Prediction of Evolution
Unruptured Intracranial Aneurysm
Nantes University Hospital1,000 enrolled21 locationsNCT04578808
Recruiting
Not Applicable
CongenItal Naevus Cohort for Longitudinal Evaluation
NaeviNeurodevelopmental DisorderCongenital Nevus
Nantes University Hospital819 enrolled16 locationsNCT06828822
Recruiting
Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies)
LaminopathiesEmerinopathies
Pitié-Salpêtrière Hospital800 enrolled28 locationsNCT03058185